Ativan and Brilinta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ativan (lorazepam) and Brilinta (ticagrelor). Common drug interactions include ocular hyperaemia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Ativan and Brilinta. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Ativan?

Ativan has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 78,506 Ativan users. Check the latest studies of Ativan.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.



On Jul, 16, 2026

69 people who take Ativan and Brilinta together, and have interactions are studied.

Ativan and Brilinta drug interactions.

What are the common drug interactions of Ativan and Brilinta, by gender? *:

female:

  1. Ocular hyperaemia (an abnormally large amount of blood in eye)
  2. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  3. Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
  4. Pyrexia (fever)
  5. Renal failure (kidney dysfunction)
  6. Ruptured cerebral aneurysm (bleeding from brain)
  7. Sacroiliitis (an inflammation of the sacroiliac joint)
  8. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  9. Swelling
  10. Uveitis (inflammation of the uvea)

male:

  1. Drug ineffective
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Vomiting
  4. Blood pressure increased
  5. Intestinal obstruction
  6. Muscle spasms (muscle contraction)
  7. Abscess limb (limb infection)
  8. Essential tremor
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Psychomotor hyperactivity (feelings of extreme restlessness)

What are the common drug interactions of Ativan and Brilinta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Epistaxis (bleed from the nose)
  2. Haemorrhagic diathesis (bleeding tendency)
  3. International normalised ratio increased
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Nephrolithiasis (calculi in the kidneys)

20-29:

n/a

30-39:

  1. Blood pressure increased
  2. Intestinal obstruction
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Renal failure (kidney dysfunction)
  5. Cardiac disorder
  6. Chronic kidney disease
  7. Depression
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Nephrolithiasis (calculi in the kidneys)

40-49:

  1. Bradycardia (abnormally slow heart action)
  2. Chronic kidney disease
  3. Drug ineffective
  4. Electrocardiogram qt prolonged
  5. Fatigue (feeling of tiredness)
  6. Mycobacterium chelonae infection (bacterial infection)
  7. Obesity (having too much body fat)
  8. Renal disorder (kidney disease)
  9. Renal failure (kidney dysfunction)
  10. Snoring

50-59:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  3. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Diarrhoea
  6. Dizziness
  7. Drug hypersensitivity
  8. Dyspnoea at rest (difficult or laboured breathing during rest)
  9. Gait disturbance
  10. Gallbladder disorder

60+:

  1. Chronic kidney disease
  2. Blood glucose increased
  3. Dyspnoea (difficult or laboured respiration)
  4. Exostosis (formation of new bone on the surface of a bone)
  5. Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells)
  6. Rash
  7. Red cell distribution width increased
  8. Sinusitis (inflammation of sinus)
  9. Arthralgia (joint pain)
  10. Blood glucose decreased

What are the existing conditions these people have? *

  1. High Blood Pressure: 15 people, 21.74%
  2. Pain: 12 people, 17.39%
  3. Heart Attack: 9 people, 13.04%
  4. Depression: 9 people, 13.04%
  5. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 8 people, 11.59%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 8.70%
  7. Multiple Myeloma (cancer of the plasma cells): 6 people, 8.70%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 8.70%
  9. Dyslipidaemia (abnormal amount of lipids): 6 people, 8.70%
  10. Diabetes: 6 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Ativan and Brilinta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ativan and Brilinta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ativan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Brilinta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ativan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Brilinta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and ticagrelor (the active ingredients of Ativan and Brilinta, respectively), and Ativan and Brilinta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: